Omdahl J L
J Biol Chem. 1978 Dec 10;253(23):8474-8.
Parathyroid extract and 1,25 dihydroxyvitamin D3 (1,25-(OH)2D3) were found to antagonize each other's action to regulate the kidney hydroxylation of 25-hydroxyvitamin D3. Parathyroid extract prompted an increase in serum 1,25-(OH)2D3 in thyroparathyroidectomized rats whereas the administration of exogenous 1,25 (OH)2D3 resulted in stimulated 24,25-dihydroxyvitamin D3 and suppressed 1,25-(OH)2D3 serum levels. The actions of parathyroid and 1,25-(OH)2D3 to modulate kidney 25-hydroxyvitamin D3 hydroxylase enzyme activities were not additive; rather, the hormone and metabolite acted to suppress each other's in vivo regulatory action. The specificity and rate of 25-hydroxyvitamin D3 hydroxylation was determined by the interdependent modulatory actions of parathyroid extract and 1,25-(OH)2D3. Such results suggest that the kidney 25-hydroxyvitamin D3-1- and 24-hydroxylase enzyme systems are regulated in response to the relative modulatory activities of parathyroid hormone and 1,25-(OH)2D3.
甲状旁腺提取物和1,25 - 二羟维生素D3(1,25-(OH)2D3)被发现相互拮抗对方调节肾脏25 - 羟维生素D3羟化作用。甲状旁腺提取物可促使甲状旁腺切除大鼠血清1,25-(OH)2D3水平升高,而给予外源性1,25-(OH)2D3则导致24,25 - 二羟维生素D3升高且1,25-(OH)2D3血清水平降低。甲状旁腺和1,25-(OH)2D3调节肾脏25 - 羟维生素D3羟化酶活性的作用并非相加性的;相反,该激素和代谢产物在体内相互抑制对方的调节作用。25 - 羟维生素D3羟化的特异性和速率由甲状旁腺提取物和1,25-(OH)2D3的相互依赖调节作用决定。这些结果表明,肾脏25 - 羟维生素D3 - 1 - 羟化酶和24 - 羟化酶系统是根据甲状旁腺激素和1,25-(OH)2D3的相对调节活性来调节的。